Fig. 10From: Construction of a novel necroptosis-related lncRNA signature for prognosis prediction in esophageal cancerInvestigation of tumor immunotherapy. A 6 immune functions significantly activated in the high-risk group. B The differences of immune checkpoint expressions between the high- and low-risk groups. C the prediction of potential therapeutic compounds for the risk modelBack to article page